https://www.selleckchem.com/products/ABT-888.html
https://www.selleckchem.com/products/ABT-888.html
Trial and error The field of biology 2021 Assembly Abstracts. No significant difference in all-cause mortality at 30-day was observed between early and non-early TAVI groups (5% vs 10%; p = 0.617). All-cause mortality at 2-year was lower in the early TAVI groups (16% vs 40%, log-rank p = 0.022); however, after multivariable adjustment, the difference was barely statistically significant (p = 0.053). In conclusion, TAVI in patients with AHF was associated with worse short and long-t
お気に入り
コメント
シェア
